Announcements Trials
Browse Landscape

Phase

Phase 2 88Phase 1 64Phase 1/2 19Phase 3 14Phase EARLY_PHASE1 6Phase NA 5Phase 2/3 2Phase 4 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Small Cell Lung Carcinoma 1Retinoblastoma 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Topotecan × Clear all
NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting
225 enrolled
Other solid neoplasm

Retinoblastoma

NCT07106528 2025-08-06

Organoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung Cancer

Peking Union Medical College Hospital

Phase 2/3 Not yet recruiting
128 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡